- Chief Compliance Officer and VP of Legal Affairs, Arrow Electronics
By Adrianne Appel2023-03-14T16:38:00
A Pennsylvania-based company that designs industrial wastewater treatment and filtration plants agreed to pay $8.5 million to resolve charges it misstated its revenue in filings with the Securities and Exchange Commission (SEC).
The SEC announced Monday it charged Evoqua Water Technologies Corp. and a former company finance director, Imran Parekh, with improper accounting practices in the firm’s 2017 and 2018 filings with the agency.
The SEC alleged Parekh, as finance director of Rhode Island-based acquisition Neptune Benson, inflated revenues by nearly $12 million for fiscal year 2017 as Evoqua was preparing to go public.
2024-05-16T18:52:00Z By Jeff Dale
Evoqua Water Technologies agreed to pay $8.5 million as part of a nonprosecution agreement with the Department of Justice to settle admitted criminal charges related to fraudulent revenue recognition.
2023-04-19T16:46:00Z By Jeff Dale
New York-based investment adviser Betterment agreed to pay $9 million to settle charges levied by the Securities and Exchange Commission over material misstatements and omissions related to its automated tax loss harvesting service.
2023-03-30T17:13:00Z By Kyle Brasseur
Spicer Jeffries and one of its audit engagement partners were spared financial penalties in settling with the Securities and Exchange Commission over allegations of improper professional conduct during the audits of two private funds.
2025-07-07T19:02:00Z By Aaron Nicodemus
The Consumer Financial Protection Bureau has dropped a $95 million enforcement action against Navy Federal Credit Union, the latest regulatory pullback by the agency under President Donald Trump.
2025-07-07T17:45:00Z By Neil Hodge
The UK’s financial regulator has had a rough ride over the past couple of years as its strategy to “name and shame” firms it opened investigations into was widely slammed by the industry and lawmakers over concerns that companies could be unfairly maligned.
2025-07-02T18:31:00Z By Aaron Nicodemus
Emerging enforcement priorities of the U.S. Department of Justice’s health care fraud division align with the Trump administration’s emphasis on prosecuting transnational criminal organizations and ending opioid trafficking.
Site powered by Webvision Cloud